Symbol
| SLAMF1
| contributors: mct - updated : 16-02-2017
|
HGNC name
| signaling lymphocytic activation molecule family member 1
|
HGNC id
| 10903
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
|  
| loss of function
|
in Chronic lymphocytic leukemia (CLL) modulates genetic pathways that regulate chemotaxis and autophagy and that potentially affect drug responses | constitutional
|  
|  
| --over
|  
|
significantly increased expression of SLAMF1 by CD3+CD4+ helper T cells and CD19+ B cells in patients with SLE and active disease | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| new diagnostic marker in CNS tumors | Therapy target
|
System | Type | Disorder | Pubmed |
cancer | brain | | |
potential target for novel therapeutic approaches in CNS tumors |
| | |